New Delhi: According to the National Health Commission, China, the death toll due to the viral outbreak of the coronavirus currently stands at 2,835, and the number of infected people is more than 79,000. The cases of the coronavirus are being reported from all over the world, with 205 new cases reported in the last day, from Iran.
In a situation where coronavirus outbreak is becoming a global pandemic, a vaccine against the virus is one of the few flickering hopes we have. According to recent reports, a biotech company says that the first vaccine against coronavirus is now ready for a human trial.
US Biotech Firm, Moderna, has sent an experimental coronavirus vaccine to the US government researchers, in a time period as short as six weeks from the time they started working on the immunisation. The trials of the vaccine could begin in April, but the whole process of testing and approvals could take at least a year.
Moderna (MRNA), the biotech company, in a press release statement on Monday, said that the first batch of the COVID-19 vaccine called the mRNA-1273 has been sent to the National Institute of Allergy and Infectious Diseases. The biotech company also said that the first trial would be conducted on a small number of healthy people, in the planned Phase 1 of the study for the vaccine. According to a report on CNN, around 45 people will participate in the first trial.
However, even if the first phase of testing is successful, further testing, regulatory approvals, etc. will be needed before the vaccine can be used for immunisation against the novel coronavirus.
Moderna, however, is not the only biotech company looking out to find immunisation against the virus. Other global pharma giants are also working on a vaccine, and so are government scientists. However, the little time in which researchers have made the vaccine ready for human trial is remarkable. As compared to the 2002 SARS outbreak, and a vaccine developed against it, the time taken to develop the experimental vaccine is a breakthrough. According to reports, scientists were ready with the vaccine within 42 days of receiving genetic information about the coronavirus, while the vaccine for the SARS virus took about 20 months to be ready for a human trial.